cd4+cd25+cd127lowfoxp3+ t regulatory cells
Cell therapyexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2011 (NCT01446484)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- T-lymphocytesSupplementation
T-lymphocytes supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- cd4+cd25+cd127lowfoxp3+ t regulatory cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01446484 | Phase 1/Phase 2 (Phase 2) | Oct 1, 2011 | Pirogov Russian National Research Medical University, Russian Academy of Medical Sciences, Russian State Medical University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pirogov Russian National Research Medical University | Academic/Hospital | 1 | 1 | 1 | 2011 |
| Russian Academy of Medical Sciences | Academic/Hospital | 1 | 0 | 1 | 2011 |
| Russian State Medical University | Academic/Hospital | 1 | 0 | 1 | 2011 |
3 organizations
Page 1 / 1